Zobrazeno 1 - 7
of 7
pro vyhledávání: '"D Y, Logunov"'
Autor:
I. A. Kirillov, A. P. Pirozhkov, V. V. Rubtsov, S. Ya. Loginova, N. A. Saifulina, T. M. Plekhanova, M. A. Timofeev, D. A. Kutaev, D. Y. Logunov, A. L. Gintsburg, S. V. Borisevich
Publikováno v:
Биопрепараты: Профилактика, диагностика, лечение, Vol 22, Iss 4, Pp 435-445 (2022)
In November 2020, the Armed Forces of the Russian Federation began mass immunisation of the personnel with Gam-COVID-Vac (Sputnik V), the first Russia vaccine against the new coronavirus infection (COVID-19). Thus, it became necessary to assess post-
Externí odkaz:
https://doaj.org/article/00776c202db34d0299d4f0ad75982e9f
Autor:
A. A. Latanova, S. Petkov, A. Kilpelainen, J. Jansons, O. E. Latyshev, Y. V. Kuzmenko, J. Hinkula, M. A. Abakumov, V. T. Valuev-Elliston, M. Gomelsky, V. L. Karpov, F. Chiodi, B. Wahren, D. Y. Logunov, E. S. Starodubova, M. G. Isaguliants
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-22 (2018)
Abstract DNA vaccines require a considerable enhancement of immunogenicity. Here, we optimized a prototype DNA vaccine against drug-resistant HIV-1 based on a weak Th2-immunogen, HIV-1 reverse transcriptase (RT). We designed expression-optimized gene
Externí odkaz:
https://doaj.org/article/1b38b6e3c64d4d089d2e1bc152026848
Autor:
I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatulin, A. S. Dzharullaeva, N. M. Tukhvatulina, D. V. Shcheblyakov, M. M. Shmarov, E. A. Tokarskaya, Y. V. Simakova, D. A. Egorova, D. N. Scherbinin, I. L. Tutykhina, A. A. Lysenko, A. V. Kostarnoy, P. G. Gancheva, T. A. Ozharovskaya, B. V. Belugin, L. V. Kolobukhina, V. B. Pantyukhov, S. I. Syromyatnikova, I. V. Shatokhina, T. V. Sizikova, I. G. Rumyantseva, A. F. Andrus, N. V. Boyarskaya, A. N. Voytyuk, V. F. Babira, S. V. Volchikhina, D. A. Kutaev, A. N. Bel'skih, K. V. Zhdanov, S. M. Zakharenko, S. V. Borisevich, D. Y. Logunov, B. S. Naroditsky, A. L. Gintsburg
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 613-620 (2017)
Ebola hemorrhagic fever, also known as Ebola virus disease or EVD, is one of the most dangerous viral diseases in humans and animals. In this open-label, dose-escalation clinical trial, we assessed the safety, side effects, and immunogenicity of a no
Externí odkaz:
https://doaj.org/article/847acaea0f3742c5b47c8188f24da836
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 9, Iss 4, Pp 49-53 (2017)
Retroviruses are a single-stranded RNA viruses that introducetheir genes into host cells genome. Genes of retroviruses compose9.3% of human genome. These genes may influence humangenome activity by changing its structure and stability, introducingreg
Externí odkaz:
https://doaj.org/article/400f4f66a84543ff8dbc060dfe919e15
Autor:
Elizaveta P. Zinina, S. V. Tsarenko, D. Y. Logunov, A. I. Tukhvatulin, M. A. Magomedov, A. V. Babayants, A. A. Avramov
Publikováno v:
Annals of Critical Care. :48-58
Objectives. This study was performed to find changes in the plasma cytokine profile of neuroresuscitation patients with ventilator-associated pneumonia, and to search for prognostic markers of effectiveness of antibacterial treatment of ventilator-as
Autor:
I V, Dolzhikova, E A, Tokarskaya, A S, Dzharullaeva, A I, Tukhvatulin, D V, Shcheblyakov, O L, Voronina, S I, Syromyatnikova, S V, Borisevich, V B, Pantyukhov, V F, Babira, L V, Kolobukhina, B S, Naroditsky, D Y, Logunov, A L, Gintsburg
Publikováno v:
Acta Naturae
The Ebola virus disease (EVD) is one of the most dangerous infections affecting humans and animals. The first EVD outbreaks occurred in 1976 in Sudan and Zaire. Since then, more than 20 outbreaks have occurred; the largest of which (2014−2016) evol
Autor:
A I, Tukhvatulin, D Y, Logunov, I I, Gitlin, M M, Shmarov, P V, Kudan, Capital A Cyrillic А, Adzhieva, A F, Moroz, N N, Kostyukova, L G, Burdelya, B S, Naroditsky, A L, Gintsburg, A V, Gudkov
Publikováno v:
Acta Naturae
Pattern-recognition receptors (PRR) play a crucial role in the induction of the defense reactions of the immune system against pathogenic bacterial and viral infections. The activation of PRR by specific, highly conserved pathogen-associated molecula